ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Sage Therapeutics Inc

Sage Therapeutics Inc (SAGE)

7.285
0.015
( 0.21% )
Updated: 15:22:55

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 3.29M2.47M2.72M77.97M7.9M8.65M11.87M12.82M
Operating Income -155.47M-170.46M-211.85M-42.07M-117.68M-111.3M-101.2M-102.19M
Pre Tax Income -146.83M-160.33M-201.63M-32.71M-108.48M-102.85M-93.55M-95.78M
Net Income -146.83M-160.33M-201.63M-32.71M-108.48M-102.85M-93.55M-95.78M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -155.66M-170.5M-211.9M-42.17M-117.69M-111.3M-101.19M-102.18M
EBITDA -155.15M-170.13M-211.52M-41.67M-117.34M-110.99M-100.95M-102.07M
Year End December 30 2024 20172018201920202021202220232024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 090.27M6.87M1.11B6.31M7.69M86.46M41.24M
Operating Income -273.16M-393.24M-708.12M596.23M-460.91M-546.99M-579.85M-432.37M
Pre Tax Income -270.12M-372.88M-680.24M606.07M-457.89M-532.78M-541.49M-400.67M
Net Income -270.12M-372.88M-680.24M606.07M-457.89M-532.78M-541.49M-400.67M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -6.431-7.953-13.11310.394-7.769-8.953-9.03-6.55
EBIT -273.22M-393.22M-708.04M596.48M-460.78M-546.97M-580.23M-432.34M
EBITDA -272.62M-392.1M-705.84M598.86M-456.73M-545.87M-578.46M-431.34M